Category: Workers Comp

511 posts found

Medmonitor

FDA Approves Posimir for Post-Surgical Pain Relief

A novel bupivacaine formulation works as a 72-hour local anesthetic following shoulder surgery.

This Month's Must Read

Powering People with Technology to Close Gaps Across the Life of a Claim

Healthe leaders share their thoughts with Risk & Insurance®

Clinical Insights

Xeljanz Could Increase the Risk of Heart Problems and Cancer

New data from a safety trial creates concern surrounding the rheumatoid arthritis drug.

Legislation & Policy

Wisconsin Announces Plan to Lower Prescription Drug Costs

State-led efforts to combat the drug price issue continue to emerge across the nation.

Healthe Developments

IAIABC Names Sandy Shtab Vice Chair of Associate Member Council

Healthe’s AVP of Advocacy & Compliance will provide guidance on workers’ comp regulations.

Healthe Developments

A Disruptive Year for Workers’ Comp: Insights from the 2020 Industry Survey

Join us for a panel discussion on March 10th as part of the NWCDC Digital Session Series.

Medmonitor

COVID-19 Mutations Impact Testing

False negatives may be reported due to genetic variations of the virus.

This Month's Must Read

Mobile Technology Is on Workers’ Comp Experts’ Minds: Here Are 3 Reasons They’re Right

Kristine Kennedy, SVP of Product Strategy and Innovation, talks to Risk & Insurance®

Clinical Insights

COVID-19’s Impact on Opioid Prescribing Trends

A new report from IQVIA found that national MME dropped 17% from 2019 to 2020.

Legislation & Policy

Worker Classification Debate Continues Across the Country

The Department of Labor issued a new rule while special interest groups push for regulatory change.

Opioid Developments

The Department of Justice Sues Walmart Over Role in Opioid Crisis

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.

Healthe Developments

Top 10 Disruptors of 2020 for the Workers’ Comp Industry

Initial insights from Healthesystems’ annual industry survey.

Medmonitor

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.

This Month's Must Read

The Patient Experience in Perspective: Applying Empathy to the Work Comp Claims Process

Navigating the workers’ comp process can be daunting for patients, and empathy can go a long way in improving outcomes.

Clinical Insights

IQVIA Reports on Telemedicine Trends and Opportunities

A new report explores how COVID-19 has impacted telemedicine, as well as opportunities for expansion.

Prev 1 2 3 4 5 … 18 19 20 21 22 … 31 32 33 34 35 Next